Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02266212
Other study ID # VGHKS101-016
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2011
Est. completion date September 2012

Study information

Verified date October 2023
Source Kaohsiung Veterans General Hospital.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Numbers of postoperative PCA(Patient-Controlled Analgesia) related side effects among current, past and non smokers are determined by comparing and analyzing frequency distributions. To determine whether smokers require more post operative opiate analgesics than others. Multivariate analysis will be performed to identify the major and the minor factors predicting the use of postoperative pain therapy. Our previous related study showed that the smoker male patients consumed more analgesics than those without smoking, but the female group showed the similar findings. However, the case number, especially the female cases, is underpowered. Investigators hope to increase the case number to have a better statistical and clinical significance.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date September 2012
Est. primary completion date September 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: - Patients undergoing elective general surgery are assigned to current smokers(n=100) or past smokers(n=100) or never smokers(n=100) according to the questionnaires "Fagerstrom test for nicotine dependence" 1 day prior to the surgery. Exclusion Criteria: - the patients undergoing major thoracic cardiovascular surgery - the patients with significant lung lesion - the patients with conscious disturbance - the patients with allergic history to morphine

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
5 ml arterial blood
A sample of 5 ml arterial blood will be withdraw to test the arterial blood oxygen saturation, CO2 content, carbon monoxide (CO) content and carboxyhemoglobin (COHg).

Locations

Country Name City State
Taiwan Kaohsiung Veterans General Hospital Kaohsiung

Sponsors (1)

Lead Sponsor Collaborator
Kaohsiung Veterans General Hospital.

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Other Morphine consumption Differences in postoperative morphine consumption between the 3 groups Post-operation Day1 to Day4
Other side effects site effects include dizzy, vomit, lethargic sleep and pruritus Post-operation Day1 to Day4
Primary Fagerstrom test for nicotine dependence Post-operation Day1 to Day4
Secondary Differences in pain intensity between the three groups after postoperative analgesia. Patients will give a pain score from 0 to 10. 10 is the most painful score. Post-operation Day1 to Day4
See also
  Status Clinical Trial Phase
Withdrawn NCT00180622 - Markers for Chronic Obstructive Pulmonary Disease (COPD)
Completed NCT01928901 - Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC) Phase 2